ALLOZYNE INC
Biotechnology · Seattle, WA
Uradni registerski podatki
0sledilcev
2005ustanovljeno
O ALLOZYNE INC
Allozyne was a clinical stage biotechnology company headquartered in Seattle's biotech and high tech innovation corridor. Allozyne was founded in 2005 by California Institute of Technology researchers, and was incubated by Accelerator Corporation. Its lead product candidate, AZ01, is a long acting interferon beta for the treatment of the relapsing remitting form of multiple sclerosis, a chronic degenerative disease characterized by demyelination of nerve fibers leading to severe nerve damage and increasing disability. Multiple sclerosis is estimated to affect 400,000 individuals in the US alone and 2.5 million worldwide. AZ01 is currently undergoing Phase I clinical trials in the US. Preclinical data indicates that AZ01 has the potential to be dosed once monthly compared to the current standard of care dosed anywhere from once daily to once per week.
Source: Wikipedia
PanogaBiotechnology
SedežSeattle, WA
Ustanovljeno2005
Pravna oblikaC Corporation
StatusAktivno
Ključne številke
Prijavite se, da si ogledate ključne številke
Prihodki, čisti dobiček in število zaposlenih podjetja ALLOZYNE INC skozi leta, z njihovimi viri.
Prijavite se Ustvarite račun s svojim e-poštnim naslovomBrezplačno je
Z nadaljevanjem se strinjate z uporabniško pogodbo, pravilnikom o zasebnosti in pravilnikom o piškotkih družbe Heelky.
Pravne informacije
| Pravno ime | ALLOZYNE INC |
|---|---|
| Pravna oblika | C Corporation |
| SEC CIK | 1345630Ogled na SEC EDGAR ↗ |
| Registrirani naslov | Seattle, WA |
| Status | Aktivno |
Viri: SEC EDGAR · posodobljeno 14. november 2026
Stik in povezave
Lokacija
Seattle, WA
Je to vaše podjetje?
To stran brezplačno prevzemite, da dodate logotip, izdelke, fotografije in zaposlitve ter odgovorite na mnenja.
Prevzemite to stranPridružite se Heelky, da se povežete, zaposlite in rastete
Ustvarite brezplačen račun, da ljudem pišete, se prijavljate na zaposlitve in objavljate misije.
Pridruži se zdaj — brezplačno je